2024³â ´ëÇѽÅÀåÇÐȸ ´ë±¸ °æºÏÁöȸ ½ÉÆ÷Áö¾ö : 2024-02-17
±³À°ÀÏÀÚ : 2024-02-17
±³À°Àå¼Ò : ´ë±¸ µ¿»êº´¿ø (µ¿»êµ¿) 3Ãþ ¸¶ÆêȦ
±³À°ÁÖÁ¦ : 2024³â ´ëÇѽÅÀåÇÐȸ ´ë±¸ °æºÏÁöȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ë±¸.°æºÏ Áöȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ : ksn@ksn.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 17ÀÏ ¸¶ÆêȦ 14:00~14:30 The Landscape of IgA Nephropathy Treatment Strategy ±è¿¹¸² (°è¸íÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ ¸¶ÆêȦ 14:30~15:00 Management of Hypertension in CKD: Beyond the Guidelines ±è¾Æ¿µ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ ¸¶ÆêȦ 15:00~15:30 Prescribing SGLT2 inhibitors in Patients with CKD Á¶ÀåÈñ(°æºÏÀÇ´ë)
ÈÞ½Ä 02¿ù 17ÀÏ ¸¶ÆêȦ 15:30~15:50 ÈÞ½Ä ()
±³À°½Ã°£ 02¿ù 17ÀÏ ¸¶ÆêȦ 15:50~16:20 New drug, Ferric citrate for Hyperphosphatemia in CKD patients ±è¼º±Ô(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02¿ù 17ÀÏ ¸¶ÆêȦ 16:20~16:50 Unsolved Skin problems in CKD patients ±è¼º¾Ö(°è¸íÀÇ´ë )
±³À°½Ã°£ 02¿ù 17ÀÏ ¸¶ÆêȦ 16:50~17:20 Comprehensive Overview of Kidney imaging ±èº´Á¦ (°è¸íÀÇ´ë )